MEDI1814
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI1814, covering 2019-06-03 to 2019-06-03. Get the full timeline:
Most recent: Clinical Trial Update: SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. [Phase 1]